Revlimid and Trileptal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Revlimid (lenalidomide) and Trileptal (oxcarbazepine). Common drug interactions include incontinence among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Revlimid and Trileptal. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.

On Jul, 14, 2026

60 people who take Revlimid and Trileptal together, and have interactions are studied.

Revlimid and Trileptal drug interactions.

What are the common drug interactions of Revlimid and Trileptal, by gender? *:

female:

Incontinence (lack of moderation or self-control)
Motion sickness (travel sickness)
Red blood cell count decreased
Vomiting
White blood cell count decreased
Abscess jaw (tooth abscess or root abscess)
Accident at home
Acute myocardial infarction (acute heart attack)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Arthralgia (joint pain)

male:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Asthma
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Fall
Gout (uric acid crystals building up in the body)
Haematuria (presence of blood in urine)
Heat stroke
Hypercalcaemia (elevated calcium (ca+) level in the blood)

What are the common drug interactions of Revlimid and Trileptal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Hepatic failure (liver failure)
Leukopenia (less number of white blood cells in blood)
Neoplasm progression (growth of tumour)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

20-29:

n/a

30-39:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

40-49:

Anaemia (lack of blood)
Asthenia (weakness)
Constipation
Cough
Dyskinesia (abnormality or impairment of voluntary movement)
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Haematocrit decreased
Haemoglobin decreased
Lethargy (tiredness)

50-59:

n/a

60+:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dehydration (dryness resulting from the removal of water)
Gout (uric acid crystals building up in the body)
Haematuria (presence of blood in urine)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypokalaemia (low potassium)

What are the existing conditions these people have? *

Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 5 people, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 6.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 5.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and Trileptal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously